Why the study?
Does hypothermic blood cardioplegia adequately preserve myocardial energy metabolism during aortic valve replacement?
Does hypothermic blood cardioplegia adequately preserve myocardial energy metabolism during aortic valve replacement?
Hypothermic blood cardioplegia provides adequate initial myocardial protection during aortic valve replacement, but significant ATP reduction and lactate accumulation occur if myocardial temperature exceeds 18 degrees C.
ATP fall and lactate rise during cross-clamping may signal suboptimal protection; hypothesis-generating for cardioplegia efficacy in AVR.
Myocardial energy metabolism during hypothermic potassium cardioplegia with blood as the cardioplegia vehicle, given in one or two bolus doses, was studied in eight patients undergoing aortic valve replacement. Myocardial biopsies were taken from the left ventricle 10 min after aortic cross-clamping (a.c.) and immediately before declamping (d.c.) and were analyzed for ATP, creatine phosphate (CP), creatine (C) and lactate. The interindividual range of myocardial temperature was 11-19 degrees C at 10 min a.c. and 11-25 degrees C immediately before d.c. The myocardial ATP concentration fell (17.2 +/- 5.7-12.8 +/- 2.8 mmol X kg-1 dry muscle), the lactate concentration rose (64.7 +/- 35.8-136 +/- 33.8 mmol X kg-1 d.m.) and the total creatine pool (CP + C) was unchanged. Hypothermic blood cardioplegia conferred fairly good initial protection of the myocardium, but the reduction in ATP and the great lactate accumulation towards the end of cardioplegia, especially in patients with myocardial temperature reaching 19-25 degrees C, indicates that such protection is adequate only if the myocardial temperature is maintained between 11 and 18 degrees C.
No takes yet. Share an insight, caveat, or question.
Jansson et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: